Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

NCT05186948 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 230

Last updated 2026-04-06

No results posted yet for this study

Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.

Conditions

  • Cancer-related Cognitive Impairment

Interventions

DEVICE

Eye-Tracking

Eye-tracking technology and algorithms used to successfully capture and track eye movements using an electronic tablet and the embedded camera of the device.

Sponsors & Collaborators

  • Innodem Neurosciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-30
Primary Completion
2025-01-20
Completion
2025-01-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05186948 on ClinicalTrials.gov